REVXF (Revenio Group Oyj) Short Ratio

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

REVXF Revenio Group Oyj REVXF
78 GF Score
Price $16.41
GF Value $41.23
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Revenio Group Oyj Short Ratio?

Short Ratio is a metric signaling prevailing investors' sentiment with a company. It represents the number of days it takes short sellers on average to repurchase all the shares short.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

REVXF
78GF Score
Revenio Group Oyj REVXF
Short Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Revenio Group Oyj (REVXF) Overvalued in 2026?

Based on GuruFocus' analysis, Revenio Group Oyj stock appears to be undervalued. The current stock price of $16.41 is trading 60.2% below its estimated GF Value™ of $41.23. GuruFocus considers Revenio Group Oyj to be Significantly Undervalued.

Key valuation signals for REVXF:

  • Short Ratio:
  • GF Value™: $41.23 vs. price of $16.41 (60.2% below fair value)
  • GF Score™: 78/100 with 2 warning signs

No single metric tells the full story. See the REVXF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Revenio Group Oyj Business Description

Address Harkahaankuja 7, Vantaa, FIN, 01730
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective, easy-to-use health tech-related screening devices for detecting diseases of public health significance. Its ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), and perimeter and fundus imaging devices under the iCare brand. Its eye care software platform, Oculo, offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company generates the majority of its revenue from the United States.
78GF Score

Get the complete analysis for REVXF

Short Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.41
Price
$41.23
GF Value